# Pierre Fabre Pharmaceuticals, Inc. – FDA Inspection, Jul 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/5e316c74-1c4a-4b0e-8a3f-5c9b20cfd3fd
Source feed: FDA_Inspections

> FDA inspection 1175515 of Pierre Fabre Pharmaceuticals, Inc., July 27, 2022. Classification: Voluntary Action Indicated (VAI). 6 citations under 21 CFR part 314. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175515
- Company Name: Pierre Fabre Pharmaceuticals, Inc.
- Inspection Date: 2022-07-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 1253273 - 2024-11-01](https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/01cb2931-62ce-4bde-84b6-ab813b5e54a6)
- [FDA Inspection 956345 - 2015-12-30](https://www.keypedia.com/records/fda_inspections/pierre-fabre-pharmaceuticals-inc/140fdda4-ba34-4f68-82d6-163a0645a609)

Company: https://www.keypedia.com/companies/pierre-fabre-pharmaceuticals-inc/ee0282e8-44f7-43c1-b3d5-fdc0c75129dc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c